Recurrent Cholangiocarcinoma
4 clinical trials · Condition
◉ Watch Recurrent Cholangiocarcinoma
| Record | Firm | Date |
|---|---|---|
| Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations (NCT03212274) | National Cancer Institute (NCI) | 2019-01-30 |
| Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer (NCT03257761) | University of Southern California | 2018-02-07 |
| Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma (NCT02856568) | Mayo Clinic | 2017-05-01 |
Track Recurrent Cholangiocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.